Press Release: Enzymatics : ArcherDX Launches from QIAGEN Acquisition of Enzymatics

BOULDER, Colo. & BEVERLY, Mass.--(BUSINESS WIRE)--ArcherDX, the NGS applications company, has been formed from QIAGEN's acquisition of Enzymatics. ArcherDX offers FusionPlex gene fusion assays that utilize Anchored Multiplex PCR (AMP) technology.